MediBeacon TGFRTM System receives FDA approval for kidney function assessment.

INNOVATE Corp. announced that MediBeacon received FDA approval for the next-generation MediBeacon TGFRTM System, a point-of-care kidney function assessment tool that measures the clearance rate of a non-radioactive fluorescent agent. The system includes a reusable sensor and is expected to be commercialized in select academic medical centers in early 2026.